CIBACEN Side Effects

6719327-3 | Agranulocytosis, Anaemia, Aplastic Anaemia, Autoimmune Disorder, Bone Marrow Failure, Epistaxis, Fatigue, Pancytopenia
on May 05, 2010 Female patient from GERMANY , 87 years of age, weighting 114.6 lb, was treated with Cibacen (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, aplastic anaemia, autoimmune disorder, bone marrow failure, epistaxis, fatigue, pancytopenia. Cibacen dosage: 2.5 Mg, Qd. During the same period patient was treated with WOBENZYM N (Half Dosage Form Per Day) (View Wobenzym N Review and Wobenzym N Label ), MAGNESIUM VERLA N DRAGEES (1 Dosage Form Per Day) (View Magnesium Verla N Dragees Review and Magnesium Verla N Dragees Label ). Patient was hospitalized.

6442057-2 | Petit Mal Epilepsy
Patient was taking Cibacen (View Usage). Patient had the following side effects: petit mal epilepsy on Sep 30, 2009 from JAPAN Additional patient health information: Male patient , 73 years of age, . Cibacen dosage: .

6391318-4 | Petit Mal Epilepsy
Adverse event was reported on Sep 30, 2009 by a Male patient taking Cibacen (View Usage) (Dosage: ) . Location: JAPAN , 73 years of age, After Cibacen was administered, patient had the following side effects: petit mal epilepsy.

6384671-9 | Petit Mal Epilepsy
on Sep 25, 2009 Male patient from JAPAN , 73 years of age, was treated with Cibacen (View Usage). Patient experienced the following unwanted or unexpected effects: petit mal epilepsy. Cibacen dosage: .


6188888-8 | Fall, Humerus Fracture
on May 04, 2009 Female patient from FRANCE , 76 years of age, was treated with Cibacen (View Usage). Patient had the following side effects: fall (What is fall?), humerus fracture. Cibacen dosage: 10 Mg, Bid. During the same period patient was treated with VASTAREL ^BIOPHARMA^ (35 Mg, Bid) (View Vastarel ^biopharma^ Review and Vastarel ^biopharma^ Label ), OLMETEC (20 Mg, Qd) (View Olmetec Review and Olmetec Label ), LOVENOX (View Lovenox Review and Lovenox Label ), HEXAQUINE (View Hexaquine Review and Hexaquine Label ), DAFALGAN (1 G) (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

6131851-3 | Anxiety, Blood Potassium Decreased, C-reactive Protein Increased, Dizziness, Dyspnoea, Hyperhidrosis, Hypotension, Platelet Count Decreased
Patient was taking Cibacen (View Usage). After Cibacen was administered, patient had the following side effects: anxiety (What is anxiety?), blood potassium decreased, c-reactive protein increased, dizziness (What is dizziness?), dyspnoea, hyperhidrosis, hypotension, platelet count decreased on Mar 17, 2009 from GERMANY Additional patient health information: Male patient , 47 years of age, was diagnosed with hypertension, upper respiratory tract infection, pyrexia, hyperlipidaemia and. Cibacen dosage: 20 Mg, Qd. During the same period patient was treated with NOVAMIN (30 Gtt, 1 In 1 Total) (View Novamin Review and Novamin Label ), BISOPROLOL FUMARATE (5 Mg, Bid) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5323369-2 | Anaemia, Anuria, C-reactive Protein Increased, Faeces Discoloured, Gastric Ulcer, Gastrointestinal Haemorrhage, Gastrointestinal Necrosis, Haemoglobin Decreased
Adverse event was reported on May 09, 2007 by a Female patient taking Cibacen (View Usage) (Dosage: Unk, Unk) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: FRANCE , child 10 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, anuria, c-reactive protein increased, faeces discoloured, gastric ulcer, gastrointestinal haemorrhage, gastrointestinal necrosis, haemoglobin decreased. During the same period patient was treated with ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), ALDACTAZINE (View Aldactazine Review and Aldactazine Label ), CORDARONE (View Cordarone Review and Cordarone Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

5243517-2 | Bronchitis, Cataract, Cataract Operation, Cough, Productive Cough, Retinal Disorder, Retinal Operation, Syncope
on Feb 08, 2007 Female patient from GERMANY , 71 years of age, was diagnosed with hypertension and was treated with Cibacen (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), cataract (What is cataract?), cataract operation, cough, productive cough, retinal disorder (What is retinal disorder?), retinal operation, syncope. Cibacen dosage: 5 Mg, Qd.

5140221-6 | Rhabdomyolysis
on Oct 19, 2006 Male patient from JAPAN , 71 years of age, was treated with Cibacen (View Usage). After Cibacen was administered, patient had the following side effects: rhabdomyolysis. Cibacen dosage: 5 Mg/day.

5087585-X | Bronchitis, Cataract, Cataract Operation, Cough, Macular Hole, Productive Cough, Retinal Operation, Syncope
Patient was taking Cibacen (View Usage). Patient experienced the following unwanted or unexpected effects: bronchitis (What is bronchitis?), cataract (What is cataract?), cataract operation, cough, macular hole, productive cough, retinal operation, syncope on Aug 14, 2006 from GERMANY Additional patient health information: Female patient , 71 years of age, was diagnosed with hypertension and. Cibacen dosage: 5 Mg, Qd.